Tag: Novartis
Novartis and MMV report positive results of a new non-artemisinin combination...
THUR 30 SEPT, 2021-theGBJournal- As the threat of resistance to current malaria treatment grows, Novartis and MMV have reported positive results of a new...
Novartis reaches milestone delivery of 1 billion courses of anti-malarial treatment
Novartis continues to invest in research and development for next-generation antimalarials to combat the threat of artemisinin resistance
Novartis has delivered 1 billion courses of...
Lower-income countries could soon leapfrog high-income countries with AI-enabled health technologies,...
The report uses current AI best practices to draw a roadmap that can help all countries advance towards AI maturity in health
Investment in data...
New collaboration between Novartis and Africa medical supplies platform to facilitate...
THUR, SEPT 03 2020-theG&BJournal-The collaboration aims to help alleviate supply and logistical constraints in the African Union member states; Portfolio of 15 generic and...
Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of...
…Portfolio will be sold at zero-profit to governments in up to 791 eligible countries during the pandemic and until a vaccine or curative treatment...
New agreements to expand access to 20 lifesaving cancer medicines for...
Cancer Access Partnership is expected to result in a 59 percent savings on procured cancer medicines
MON, JUN 29 2020-theG&BJournal- The American Cancer Society (ACS)...
